HAV & B19 Testing Services

Tender description

This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. Additionally, the solution must also be able to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs . The solution must have the relevant UKCA marking to support this ability. Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver HAV & B19 Screening Services in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk